Eucrisa

Pharma

Arcutis moves rival to Pfizer eczema drug Eucrisa into phase 3

The product consists of the active ingredient in AstraZeneca’s oral lung drug Daliresp formulated into a cream for use on the skin of eczema patients.

Nick Paul Taylor Jan 15, 2021 10:22am

NICE U-turns to back AZ's Tagrisso in 2 lung cancer uses

Sep 11, 2020 12:14pm

#FierceMadness: Brineura, Kymriah come up big

Mar 19, 2018 11:30am

Pfizer rolls Eucrisa campaign as Dupixent heats up eczema market

Aug 23, 2017 9:48am